Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 02-May-24
Select bar for recommendation details.
Recommendations | 02-May-24 | |
---|---|---|
Buy | 1 | |
Outperform | 0 | |
Hold | 0 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in CNY
The 4 analysts offering 12 month price targets for Ascentage Pharma Group International have a median target of 30.03, with a high estimate of 35.95 and a low estimate of 22.97. The median estimate represents a 63.19% increase from the last price of 18.40.
High | 95.4% | 35.95 |
Med | 63.2% | 30.03 |
Low | 24.8% | 22.97 |
Earnings history & estimates in CNY
Average growth rate | +17.61% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +191.80% |
More ▼